Alcon Launches First Fully Personalized LASIK in the U.S. and Canada

No two eyes are the same…and now, LASIK isn’t either. Alcon’s wavelight® plus adapts treatment to every patient.

Alcon (Geneva, Switzerland) has announced the launch of wavelight® plus, the first fully personalized LASIK treatment available in the U.S. and Canada. Already introduced in China, Europe and the Asia-Pacific, the system is now making its way to North America, with a Canadian rollout planned for later this year.

Building on more than two decades of refractive surgery innovation, wavelight plus represents a new era in laser vision correction. For the first time, technology adapts to the unique characteristics of each patient’s eye to deliver a fully-tailored refractive treatment, raising the bar for both precision and predictability.

READ MORE: Alcon Rolls Out UNITY VCS and CS Systems for Cataract and Vitreoretinal Surgery

“Wavelight plus marks an exciting new chapter in Alcon’s journey to provide personalized precision in laser eye surgery,” said Alcon Senior Vice President, President, Americas, Sergio Duplan in a news release. 

How wavelight plus works

At the core of wavelight plus is ray tracing technology, powered by the Sightmap diagnostic device. Using over 100,000 data points, it creates a 3D “Digital Eye Twin” of each patient’s eyes by integrating ocular wavefront, biometry and corneal topography measurements. 

This digital model guides a personalized laser procedure—one that corrects complex vision issues with accuracy while eliminating the need for nomogram adjustments. The result? Streamlined planning for surgeons and sharper, more reliable outcomes for patients.

READ MORE: Ray Tracing, AI and the Rise of Customized LASIK

“Patients come to my practice with increasingly high expectations for their vision after surgery. With wavelight plus, I can now offer a premium, personalized treatment with a high probability of achieving visual outcomes surpassing 20/20 vision, and even pushing the boundary of visual possibilities,” said Dr. Mark Lobanoff, refractive surgeon and CEO of OVO LASIK + LENS in St. Louis Park, Minnesota (United States).

What the data shows

Early clinical results are reinforcing the technology’s promise. In a study of 200 eyes conducted by Dr. Chandra Bala (Australia), outcomes exceeded expectations. 

• 100% of myopic eyes reached 20/20 vision three months after surgery.^1-2
• 89% of myopic eyes achieved 20/16, while half reached 20/12.^1-2
• 98% were within one line of their best corrected vision before surgery.^1-2
• 94% matched or exceeded their best corrected vision after surgery.^1-2

“I’m excited to offer my patients ray tracing LASIK, a significant advancement in refractive technology that delivers better results than standard LASIK,” said Dr. Raymond Stein, medical director of the Bochner Eye Institute and professor of ophthalmology at the University of Toronto (Canada).

“With this next-generation technology, I can deliver highly personalized refractive surgery, precisely tailored to the unique optical system of each individual. It’s incredibly rewarding to help my patients achieve the lifestyle they want while advancing my practice to the forefront of ophthalmic care.” 

WATCH NOW: Explore Alcon’s Latest Surgical Innovations

What it means for patients and surgeons

For patients, LASIK has always been a life-changing decision. With wavelight plus, many may achieve 20/20 vision—or even better—freeing themselves from glasses or contacts. The technology also simplifies surgical planning for doctors, making it easier to deliver outstanding outcomes with confidence.

Surgeons interested in adopting this technology are encouraged to connect with their local Alcon representative.

Editor’s Note: See the official press release by Alcon. This content is intended exclusively for healthcare professionals. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

References

1. He G, Bala C. Ray-tracing-guided myopic LASIK: Real-world clinical outcomes. J Cataract Refract Surg. 2023;49(11):1140-1146.
2. Kanellopoulos AJ, Maus M, Bala C, et al. International multicenter, myopic and myopic astigmatism femto LASIK, customized by automated ray-tracing ablation profile calculation: A post market study. Clin Ophthalmol. 2024;18:525-536.